Table 1

Frequency tabulation of patient background characteristics: FAS, PPS and SP

Analysis populationFASPPSSP
ItemNumber of patients (%)Number of patients (%)Number of patients (%)
Number of patients21 (100.0)18 (100.0)25 (100.0)
Sex
 Male8 (38.1)8 (44.4)9 (36.0)
 Female13 (61.9)10 (55.6)16 (64.0)
Age (years)
 20≤ to <401 (4.8)1 (5.6)1 (4.0)
 40≤ to <601 (4.8)1 (5.6)2 (8.0)
 60≤ to <757 (33.3)6 (33.3)8 (32.0)
 75≤ to ≤9012 (57.1)10 (55.6)14 (56.0)
Bacterial strain
 MRSA19 (90.5)16 (88.9)20 (80.0)
 MRSE2 (9.5)2 (11.1)5 (20.0)
Diagnosis (target disease)
 Blepharitis3 (14.3)3 (16.7)3 (12.0)
 Hordeolum0 (0.0)0 (0.0)0 (0.0)
 Meibomianitis1 (4.8)1 (5.6)1 (4.0)
 Conjunctivitis14 (66.7)11 (61.1)16 (64.0)
 Dacryocystitis2 (9.5)2 (11.1)2 (8.0)
 Keratitis1 (4.8)1 (5.6)3 (12.0)
Severity
 Mild19 (90.5)16 (88.9)21 (84.0)
 Moderate2 (9.5)2 (11.1)4 (16.0)
 Severe0 (0.0)0 (0.0)0 (0.0)
  • FAS, full analysis set; PPS, per protocol set; SP, safety population.